In a similar process, SIRT1 activity was found to be lower in CD38+ NK cells from CRC patients, resulting in higher NF-κB acetylation and the release of immune-suppressing substances, such as IL-10 and TGF-β (21). The gene discussed is SIRT1; the disease is colorectal carcinoma.